
3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, Other Technologies), By Component (3D Bioprinters, Biomaterials, Scaffolds), By Application (Drug Testing
Description
3D Bioprinting Market, By Technology (Syringe/extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting, Laser-assisted Bioprinting, Other Technologies), By Component (3D Bioprinters, Biomaterials, Scaffolds), By Application (Drug Testing and Development, Regenerative Medicine, Food Testing, Research, Other Applications), By Geography (North America Europe, Asia-Pacific, Rest of the World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
The 3D bioprinting technology is used for the fabrication of the biological constructs mainly comprises of the dispensing cells onto a biocompatible scaffold utilizing a successive layers to create the tissue similar to that of the 3D structure. Artificial organs such as the renal, hepatic and the cardiac made by the 3D printing have shown the absence of vital elements that effect the working of the body.
Market Dynamics:
Population aging with the concomitant rising threat of the osteoarthritis, bone injuries and osteoporosis along with obesity are few disorders that are contributing towards the outbreak of the orthopedic grafts. Owing to its capacity to be customized for the patient specific requirements and demand for the 3D bio-printed bone will only rise in upcoming years.
Many of the manufacturing challenges are linked with the 3D Bioprinting to the price and these manufacturing and the production challenges are centered on the material difficulties and this is anticipated to hinder the growth of the global 3D bioprinting market.
The developments achieved by the Biolofe 4D and the similar initiatives and the developments by various organizations in the major market and also in the clinical industry is anticipated fuel the industry and offer the lucrative opportunities in the forecast period.
Key features of the study:
The 3D bioprinting technology is used for the fabrication of the biological constructs mainly comprises of the dispensing cells onto a biocompatible scaffold utilizing a successive layers to create the tissue similar to that of the 3D structure. Artificial organs such as the renal, hepatic and the cardiac made by the 3D printing have shown the absence of vital elements that effect the working of the body.
Market Dynamics:
Population aging with the concomitant rising threat of the osteoarthritis, bone injuries and osteoporosis along with obesity are few disorders that are contributing towards the outbreak of the orthopedic grafts. Owing to its capacity to be customized for the patient specific requirements and demand for the 3D bio-printed bone will only rise in upcoming years.
Many of the manufacturing challenges are linked with the 3D Bioprinting to the price and these manufacturing and the production challenges are centered on the material difficulties and this is anticipated to hinder the growth of the global 3D bioprinting market.
The developments achieved by the Biolofe 4D and the similar initiatives and the developments by various organizations in the major market and also in the clinical industry is anticipated fuel the industry and offer the lucrative opportunities in the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global 3D bioprinting market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global 3D bioprinting market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Major companies involved in the global 3D printing market are 3D Systems Corporation, Cyfuse Biomedical KK, GeSIM GmbH, 3D Bioprinting Solutions, Aspect Biosystems Ltd., Organovo Holdings Inc., ARCAM AB (GE Company), Cellink AB, RegenHU SA, REGEMAT 3D, EnvisionTEC GmbH and Stratasys Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market.
- Global 3D Bioprinting Market, By Technology:
- Syringe/extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Other Technologies
- Global 3D Bioprinting Market, By Component:
- 3D Bioprinters
- Biomaterials
- Scaffolds
- Global 3D Bioprinting Market, By Application:
- Drug Testing and Development
- Regenerative Medicine
- Food Testing
- Research
- Other Applications
- Global 3D Bioprinting Market, By Geography:
- North America Europe
- Asia-Pacific
- Rest of the World
Table of Contents
168 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Component
- Market Snapshot, By Application
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising geriatric population
- Operational Challenges
- 3D printing of the living devices in the medical field
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global 3D Bioprinting Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global 3D Bioprinting Market, By Technology, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030(%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Syringe/ extrusion bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Inkjet Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Magnetic Levitation Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Laser Assisted Bioprintings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- 6. Global 3D Bioprinting Market, By Component, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030(%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- 3D Bioprinters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Biomaterials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- 7. Global 3D Bioprinting Market, By Application , 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030(%)
- Y-o-Y Growth Analysis, 2017-2030
- Segment Trends
- Drug Testing and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Food Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- 8. Global 3D Bioprinting Market, By Region, 2017-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022-2030(%)
- Y-o-Y Growth Analysis, 2017-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Technology, 2017-2030, (US$ Mn)
- Market Size and Forecast and Y-o-Y Growth , By End User, 2017-2030,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Technology, 2017-2030, (US$ Mn)
- Market Size and Forecast and Y-o-Y Growth , By End User, 2017-2030,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Technology, 2017-2030, (US$ Mn)
- Market Size and Forecast and Y-o-Y Growth , By End User, 2017-2030,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Technology, 2017-2030, (US$ Mn)
- Market Size and Forecast and Y-o-Y Growth , By End User, 2017-2030,(US$ Mn)
- Middle East &Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Technology, 2017-2030, (US$ Mn)
- Market Size and Forecast and Y-o-Y Growth , By End User, 2017-2030,(US$ Mn)
- 9. Competitive Landscape:
- 3D Systems Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aspect Biosystems Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GeSIM GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cellink AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyfuse Biomedical KK
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Envision TEC GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organovo Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regen HU SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STARTASYS Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- REGEMAT 3D
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3D Bioprinting Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ARMAC AB (GE Company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 10. Section:
- Research Methodology
- About Us
- *Browse 24 market data tables and 28 figures on "Global 3D Bioprinting Market” - Global forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.